Latest Breaking News On - Heart disease prevention program - Page 1 : comparemela.com

What Level of Lp(a) Indicates Increased CVD Risk?

The threshold of Lp(a) linked to increased risk for cardiovascular events may be different for primary and secondary prevention populations, new data suggested.

United statesNathand wongRon blanksteinUniversity of californiaHarvard medical schoolJournal of the american college cardiologyHeart disease prevention programAmerican collegeIpid managementCv riskCardiovascular riskV risk factorsCardiovascular risk factorsCardiovascular risk managementCardiovascular diseaseVd cardiovascular disease

Use more precise CVD risk scores to target therapy intensity for people with diabetes

Use more precise CVD risk scores to target therapy intensity for people with diabetes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesErik swainByregina schafferNathand wongAmerican heart associationUniversity of californiaWorld congress on insulin resistanceAmerican society for preventive cardiologyHeart disease prevention programAmerican diabetes associationAmerican societyPreventive cardiologyWorld congressInsulin resistance

Type 2 diabetes: Mounjaro superior to Ozempic for weight loss

After analyzing 22 studies, researchers have concluded that Mounjaro is more effective at weight loss and blood sugar control than Ozempic and Wegovy

United statesKathleen dunganNathan wongDivision of endocrinologyOhio state university wexner medical centerHeart disease prevention programUniversity of california irvine school medicineAmerican society for preventive cardiologyMedical newsCalifornia irvine schoolAmerican societyAmerican heart association scientific sessions

Mounjaro More Effective For Weight Loss And Blood Sugar Than Ozempic And Wegovy, Researchers Say

In a new study, researchers reported Mounjaro was superior to semaglutide drugs such as Ozempic and Wegovy for diabetes management and weight loss.

United statesKathleen dunganNathan wongHeart disease prevention programUniversity of california irvine school medicineAmerican society for preventive cardiologyOhio state university wexner medical centerDivision of endocrinologyMedical newsCalifornia irvine schoolAmerican societyAmerican heart association scientific sessions

Weight-Loss Drugs Ozempic and Wegovy Can Also Protect the Heart

A new study shows that semaglutide reduces heart failure symptoms like fatigue and swelling by bringing down body weight.

United statesMartha gulatiLos angelesNathan wongSmidt heart institute at cedarsDrug administration as ozempicSinai medical centerNovo nordiskHeart disease prevention programDrug administrationSmidt heart instituteCedars sinai medical centerIrvine schoolWeight lossPharmaceutical industryPublic health